RTX, Lockheed Replenishment Demand From Iran Campaign
The US campaign against Iran has already cost taxpayers $38 billion in just five months, and the bill is still climbing as the Pentagon scrambles to replenish depleted arsenals while shipping billions of dollars of bombs to Israel.
That price tag is not just a wartime headline. It is a direct hit to the federal budget, a fresh inflation risk through disrupted energy flows and a warning that America’s stockpiles of the weapons needed for a prolonged Middle East conflict are being drawn down faster than they can be rebuilt. The Congressional Budget Office said direct costs through Aug. 1 reached $38 billion, or as much as $3 billion a month, a pace that would keep pressure on already stretched defense accounts even if fighting does not intensify further.
The scale of the expenditure underscores how quickly a regional conflict can become a macroeconomic issue for the US. The CBO said the bill includes replacing expended missiles, more flight hours and higher fuel costs, while the Pentagon inspector general disclosed losses that had not previously been made public, including four F-15E fighters, one F-35 and 30 MQ-9 drones. Officials also warned that disruption in the Strait of Hormuz could add about 0.5 percentage point to US inflation by early next year, a reminder that war spending and consumer prices can move together through oil and supply chains.
For investors, the immediate implication is not just higher government outlays but a bigger and longer procurement cycle for defense contractors. The Trump administration has told Congress it is preparing a $2.8 billion arms sale to Israel that would include 40,000 heavy bombs, among them MK 84 and BLU-117 munitions, plus bunker-busting weapons. The Pentagon has also signed seven-year emergency contracts with companies such as Raytheon to keep missile production running around the clock, signaling that replenishment demand could extend well beyond the current conflict.
The market has already been repricing that reality. Lockheed Martin, Raytheon parent RTX and Northrop Grumman have all traded with elevated volatility this year as investors balance near-term order growth against the risk that war-related deliveries deplete inventories and strain margins. Lockheed shares have slipped back below both the 50-day and 200-day moving averages, while RTX has also retreated sharply from its summer highs, suggesting the trade is no longer simply about headline missile demand but about execution, replenishment timing and whether government orders can offset the cost of rebuilding stockpiles.
The bigger strategic issue is that Washington appears to be fighting and restocking at the same time. Patriot interceptor inventories are said to be exhausted, and analysts cited in the congressional report estimate it could take at least five years to restore arsenals. That creates a policy dilemma for the administration and Congress: sustain Israel and maintain deterrence in the Gulf, or slow shipments to preserve US readiness elsewhere. Either choice has budget consequences, and both imply a larger industrial base commitment from the Pentagon.
The next catalyst for investors will be whether the conflict widens further and whether Congress approves the next tranche of munitions funding without forcing offsetting cuts elsewhere. If the fighting drags on, the war’s fiscal cost will keep rising faster than the defense sector can absorb it; if it eases, the market will turn to the multi-year replenishment order book that now looks increasingly central to the revenue outlook for major US weapons makers.
| Entity | Gains | Losses |
|---|---|---|
| RTX | ▲Higher munitions orders | ▼Stockpile strain and execution risk |
| Lockheed Martin | ▲Replenishment demand for missiles | ▼Lower readiness inventories |
| Northrop Grumman | ▲Sustained defense spending | ▼Capital tied to war replenishment |
| US taxpayers | ▲None | ▼Higher deficits and inflation pressure |